Lynch, BM;
Stern, EP;
Ong, V;
Harber, M;
Burns, A;
Denton, CP;
(2016)
UK Scleroderma Study Group (UKSSG) guidelines on the diagnosis and management of scleroderma renal crisis.
Clinical and Experimental Rheumatology
, 34
(5)
, Article Sup 100.
Preview |
Text
Denton_SRC UKSSG report 2016-final submitted version-Denton.pdf Download (350kB) | Preview |
Abstract
The UK Scleroderma Study Group developed guidelines on the diagnosis and management of scleroderma renal crisis (SRC) based on best available evidence and clinical experience. SRC is characterised by the acute onset of severe hypertension and acute kidney injury. Current strategies to reduce the associated morbidity and mortality include identifying at risk patients to aid early diagnosis. ACE inhibitor therapy should be lifelong in all patients, regardless of whether they require renal replacement therapy. Patients with SRC may recover renal function up to 3 years after the crisis, most often within 12 to 18 months.
| Type: | Article |
|---|---|
| Title: | UK Scleroderma Study Group (UKSSG) guidelines on the diagnosis and management of scleroderma renal crisis |
| Location: | Italy |
| Open access status: | An open access version is available from UCL Discovery |
| Language: | English |
| Additional information: | © Clinical and Experimental Rheumatology |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1522559 |
Loading...
Loading...Loading...Loading...Archive Staff Only
 |
View Item |
